ClinConnect ClinConnect Logo
Search / Trial NCT06768359

The Effect of Manual Acupuncture and Standard Therapy on Anxiety and Quality of Life Scores in Cancer Patients

Launched by INDONESIA UNIVERSITY · Jan 6, 2025

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how well manual acupuncture, combined with standard cancer treatments, can help reduce anxiety and improve the quality of life for cancer patients. Researchers want to find out if patients who receive acupuncture along with their usual treatments feel less anxious and have a better quality of life compared to those who get a fake (sham) acupuncture treatment instead. The study will measure anxiety levels and overall well-being using specific questionnaires.

To participate, you must be between 18 and 59 years old, have been diagnosed with cancer within the last six months, and be experiencing moderate to severe anxiety. If you join, you will receive either the real acupuncture treatment or the sham treatment for six days, along with standard therapy like medication and counseling. However, there are some health conditions that might prevent you from taking part, such as certain blood disorders or if you have had prior anxiety treatments. The trial is not yet recruiting participants, but it's designed to help understand better ways to support cancer patients' mental health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18-59 years.
  • Diagnosed with cancer in the last 6 months
  • Experiencing moderate to severe anxiety (assessed by HAM-A Score \> 24)
  • Willing to participate in this study until completion and sign an informed consent.
  • Exclusion Criteria:
  • Cancer patients with unstable hemodynamics
  • Cancer patients with brain metastases
  • Patients who have been diagnosed with anxiety disorders and have received pharmacological therapy from psychiatrists before.
  • Patients who have contraindications to manual acupuncture (there are wounds or infections at the point to be punctured, patients are allergic to stainless steel, patients are phobic of needles)
  • Patients who are uncooperative and do not allow acupuncture therapy (patients who are restless, angry)
  • Patients with poor liver function (SGOT (Serum Glutamic Oxaloacetic Transaminase) /SGPT (serum glutamate pyruvate transaminase)values increase 2-3 times the normal value)
  • Patients with blood clotting disorders (platelets \<50,000, INR (International Normalized Ratio) \> 2)
  • Patients with neutropenia (Absolute neutrophil count \<1000)
  • Patients with overt DIC (disseminated intravascular coagulation) and acute venous or arterial thrombosis

About Indonesia University

Indonesia University is a leading academic institution dedicated to advancing healthcare through rigorous clinical research. As a trial sponsor, the university leverages its extensive expertise in medical science and collaboration with top-tier researchers to design and implement innovative clinical trials. Committed to ethical standards and patient safety, Indonesia University aims to contribute to the global body of knowledge in medicine, enhance therapeutic options, and improve health outcomes for diverse populations. Through its comprehensive approach, the university fosters an environment of scientific inquiry and collaboration, driving progress in clinical research and education.

Locations

Jakarta Pusat, Dki Jakarta, Indonesia

Patients applied

0 patients applied

Trial Officials

KEPK FKUI-RSCM

Principal Investigator

The Health Research Ethics Commitee of Faculty of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported